Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

In the corners of social media dominated by wellness content, influencers recommend an assortment of treatments and products ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Counterfeit medications are a growing menace, with alarming revelations surfacing about dangerous fake weight-loss drugs circulating among consumers. U.S. and UK health authorities have issued urgent ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

The FDA and CDC are warning consumers to be wary of sweet treats imported by Canada-based Piu Che Dolci Inc. which may have been 'sold individually or in smaller packages.' ...

While anecdotal evidence suggests those taking the type 2 diabetes drug with a side effect of weight loss may lead to hair ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

One popular and affordable supplement that has shown some promise in helping with weight loss is berberine. In fact, some have called the supplement “nature’s Ozempic,” and with a month’s supply ...

University of Ottawa students are pioneering a project to make Ozempic accessible by growing it at home using biopharming.

Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...